Drug companies and agents have taken note that from July 1st, large-scale increases will be subject to strong national monitoring.

The pharmaceutical industry with gold sales long-term existenceA large number of agents because of the lack of business authenticity, high tax costs and the corresponding company withdrawal difficulties and other reasons, either to buy tickets or to ask pharmaceutical manufacturers to solve the direct private payment of large amounts of promotional costs of cashAlways think it's safe and avoids riskin fact, enterprises or individual bank account withdrawals, transfers and other large withdrawals are bound to be subject to state monitoringFrom July 1st, the large cash management pilot began!Chinese the newly issued "Notice of the Chinese People's Bank on the pilot of large cash management", decided to start in July 2020 in Hebei Province, Zhejiang Province and Shenzhen City to carry out large-scale cash management pilot:1, the pilot significance for the establishment of large cash management long-term mechanism to lay the foundation, that is, through the three provinces and cities pilot, sum up the accumulation of experience, and then possibly to the whole country2, time and place pilot for 2 years, first in Hebei Province, and then extended to Zhejiang Province, ShenzhenStarting in July 2020, Hebei Province has been pilotingStarting in October 2020, Zhejiang Province and Shenzhen have been piloting3, the starting point of the amount, three provinces and cities to public accounts (including individual industrial and commercial households to public accounts) cash access of more than 500,000 yuan, Hebei Province to private accounts of more than 100,000 yuan, Zhejiang Province to private accounts of more than 300,000 yuan, Shenzhen to private accounts of more than 200,000 yuan, belong stake in the category of large-scale cash management4, large access to register the customer withdrawal, deposit above the starting amount of cash, should be in the processing of business registrationCommercial banks shall also report relevant information to the central branches of the People's Bank of China5, cash-in-kind traceability pilot line to consider the People's Bank of China's crown number data set data set requirements and large cash monitoring requirements, guide banking financial institutions to achieve the starting point above the access business information and cash in kind of crown number associated with traceabilityfrom the content of the file analysis, the starting point of the amount includes both a single, but also a number of cumulative, cumulative period should be a natural dayManagement business situation to have cash-in-kind handover of the counter business-oriented, including through large high-speed withdrawal equipment self-service withdrawal situation, and must be for the split, cash hidden postings and other circumvention of supervision, "pseudo-large cash transactions" situation to develop preventive measures, both to monitor a single transaction over the starting amount, but also to monitor a number of transactions that have accumulated more than the starting amountcommercial bribery and coupon-free for pharmaceutical companies, CSos and agents! this regulation of large-scale cash management curbs unreasonable demand, curbs illegal demand, and combats large-scale cash crime Because of the characteristics of bearer and untraceable cash, large amounts of cash are easy to facilitate money-laundering crimes such as corruption, hospital kickbacks, tax evasion and other underground economic activities private transfer, withdrawal of cash, the boss's private account and the company to the public account frequent capital transactions are facing control, coupled with banks, tax has been shared information, financial institutions and tax departments and other cooperation increased, the medical industry and other departments have also achieved information sharing, private account sume abnormal changes in funds are easy to be found CSO and CSP fund processing schemes are more risky Hope that through CSO, CSP company, to achieve ticketing, cash, this small trick has long been recognized, the tax department wants to check the business situation of enterprises whether there are anomalies, invoice data, tax return data is true, big data will automatically compare analysis, once the detection of dynamic data is not right, low tax rate, the system will automatically alarm pharmaceutical companies must not bet on their important marketing behavior to build their own false CSO system, to be sure that the result of this will not only not enhance marketing, more huge financial risks, and ultimately not worth the loss in the long run, pharmaceutical companies want to avoid the risks of money laundering, commercial bribery, kickbacks, etc., there is only the last and only way: compliance, compliance academic promotion Compliance of the real marketing, early to do late, sooner or later have to face! national policy continued to hit hard, all policies are in reverse to force the pharmaceutical industry to gradually go to compliance, many pharmaceutical companies were punished, the bloody lessons of supervision are still playing out, if you just go the old way, it can only be a dead road.